Prognostic factors for maximally or optimally cytoreduced stage III nonserous epithelial ovarian carcinoma treated with carboplatin/paclitaxel chemotherapy

---

Copy For Citation

Cuylan Z. F., Meydanli M. M., Sari M. E., Akbayir O., Celik H., Dede M., ...More

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, vol.44, no.7, pp.1284-1293, 2018 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 44 Issue: 7
• Publication Date: 2018
• Doi Number: 10.1111/jog.13663
• Journal Name: JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.1284-1293
• Hacettepe University Affiliated: Yes

Abstract

ObjectiveTo identify factors predictive of poor prognosis in women with stage III nonserous epithelial ovarian cancer (EOC) who had undergone maximal or optimal primary cytoreductive surgery (CRS) followed by six cycles of intravenous carboplatin/paclitaxel chemotherapy.